Biological Therapy in Treating Patients With Glioblastoma Multiforme
Status:
Completed
Trial end date:
1998-07-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Biological therapies use different ways to stimulate the immune system and stop
cancer cells from growing.
PURPOSE: Phase II trial to study the effectiveness of biological therapy in treating patients
with glioblastoma multiforme.